Free Newsletter
FDA panel: No cold meds for under-6 kids
The concerns about cough-and-cold meds for kids culminated Friday in an FDA advisory group vote against the products. The expert group concluded that there's not enough evidence that the drugs work--and plenty of evidence that they can be harmful--so they shouldn't be used in children under the age of 6.
The 13-to-9 decision was by no means unanimous, though. Some panelists believe parents depend on the drugs for help when a child is sick. Americans spend more than $300 million a year on these products. The agency probably will work with the industry to come up with a voluntary action plan, because formal proceedings could take years, FDA officials told the Washington Post.
- read the report from the Washington Post
Related Articles:
FDA experts mull ban on child cold meds. Report
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





